Letter to the editor

Clinical Therapeutics

Volumn 27, Issue 4, 2005, Pages 509-510

  Ahmed, M H ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; AMINOGUANIDINE; CHLOROQUINE; GLOBOTRIAOSYLCERAMIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; ANTIMALARIAL AGENT; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME DEFICIENCY; FABRY DISEASE; GLOMERULONEPHRITIS; GLOMERULUS; GLOMERULUS FILTRATION RATE; HEART MUSCLE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY EPITHELIUM; KNOCKOUT GENE; LETTER; LIPIDOSIS; LONG TERM EXPOSURE; MEDLINE; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PODOCYTE; RENAL PROTECTION; RHEUMATOID ARTHRITIS; SKELETAL MUSCLE; SMOOTH MUSCLE; STORAGE; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE INJURY; URINE FLOW RATE; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; PATHOLOGY;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; GLOMERULONEPHRITIS; HUMANS; LIPIDOSES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 22044433141     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(05)00072-X     Document Type: Letter

References (11)

1. Ahmed M.H., Ashton N., and Balment R.J. Renal function in a rat model of analgesic nephropathy: Effect of chloroquine J Pharmacol Exp Ther. 305 2003 123 130
2. Ducharme J., and Farinotti R. Clinical pharmacokinetics and metabolism of chloroquine Clin Pharmacokinet. 31 1996 257 274
3. Albay D, Adler SG, Philipose J, et al. Chloroquine-induced lipidosis mimicking Fabry disease. Mod Pathol. In press.
4. Müller-Höcker J., Schmid H., and Weiss M. Chloroquine-induced phospholipidosis of the kidney mimicking Fabry disease: Case report and review of the literature Hum Pathol. 34 2003 285 289
5. Roos J.M., Aubry M.C., and Edwards W.D. Chloroquine cardiotoxicity: Clinicopathologic features in three patients and comparison with three patients with Fabry disease Cardiovasc Pathol. 11 2002 277 283
6. Ghigo D., Aldieri E., and Todde R. Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells J Clin Invest. 102 1998 595 605
7. Abiose A.K., Grossmann M., and Tangphao O. Chloroquine-induced venodilation in human hand veins Clin Pharmacol Ther. 61 1997 677 683
8. Ahmed M.H., Ashton N., and Balment R.J. The effect of chloroquine on renal function and vasopressin secretion: A nitric oxidedependent effect J Pharmacol Exp Ther. 304 2003 156 161
9. Kone B.C. Nitric oxide in renal health and disease Am J Kidney Dis. 30 1997 311 333
10. Ling H., Edelstein C., and Gengaro P. Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice Am J Physiol. 277 1999 F383 F390
11. Noiri E., Peresleni T., Miller F., and Gofgorsky M.S. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia J Clin Invest. 97 1996 2377 2383